-
Enhanced Antitumor Efficacy and Reduced Toxicity in Colorectal Cancer Using a Novel Multifunctional Rg3- Targeting Nanosystem Encapsulated with Oxaliplatin and Calcium Peroxide
24 Jan 2025 10:21 GMT
… amplify autophagy to assist oxaliplatin chemotherapy against colorectal cancer … Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via … cisplatin resistance in lung cancer by downregulating PD- … advanced non-small cell lung cancer in China: a …
-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
05 Feb 2025 06:24 GMT
… of extensive-stage small cell lung cancer (ES-SCLC).
MVASI … extensive-stage small cell lung cancer (ES-SCLC) with … have received prior fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy … -squamous non-small cell lung cancer.
A randomized, double- …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… doxorubicin, pirarubicin, irinotecan, oxaliplatin, cisplatin, gemcitabine, etc … drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis … pathologic assessment of lung cancer resection specimens …
-
Pfizer’s BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
03 Feb 2025 12:13 GMT
… ®) and mFOLFOX6 (fluorouracil, leucovorin and oxaliplatin) in patients with metastatic colorectal … , and thoracic cancers, which includes lung cancer. Driven by science, we are …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
31 Jan 2025 12:21 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
03 Jun 2024 12:19 GMT
… to biomarkers.
About Lung Cancer
Lung cancer is the leading cause … positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Identification of EARS2 as a Potential Biomarker with Diagnostic, Prognostic, and Therapeutic Implications in Colorectal Cancer
30 Jan 2025 14:33 GMT
… including melanoma, breast cancer, lung cancer, gastrointestinal cancer, urogenital cancer, … IWP-2, lenalidomide and oxaliplatin, in high- and low … by drug sensitivity. Oxaliplatin is a commonly used … colorectal cancer cells to oxaliplatin by targeting HIF-1 …
-
Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer
29 Apr 2024 13:13 GMT
… and targeted treatments for lung cancer by harnessing the … biological bombs for efficient lung cancer therapy. J Colloid … KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and … ROS-dependent apoptosis in oxaliplatin-resistant colorectal cancer …
-
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
29 Jan 2025 18:00 GMT
… fluorouracil, leucovorin, and oxaliplatin) for the treatment … Cell Lung Cancer Market Non-small Cell Lung Cancer Market … Small-Cell Lung Cancer Market Small-Cell Lung Cancer Market Insight … Small-Cell Lung Cancer Pipeline Small-Cell Lung Cancer Pipeline Insight …
-
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
07 Feb 2024 12:27 GMT
… cancers to date, including lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading … with a fluoropyrimidine, oxaliplatin, and irinotecan. This … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
About
© 1995-2025